APHA is now using the term "mpox" instead of "monkeypox" per the November 2022 recommendation from the WHO. Previously produced pieces and external links may still use “monkeypox.”

U.S. public health officials are on alert for cases of mpox, a rare disease caused by a virus. People with mpox get a rash that may be located near their genitals or on other areas such as the hands, chest or face. While the disease is not often fatal, it can be very painful.

Because of its spread in the U.S. and other countries, the World Health Organization declared the 2022 mpox outbreak a public health emergency in July, and the White House followed suit in August.

The Centers for Disease Control and Prevention recommends vaccination for people who have been exposed to mpox as well as those who may be more likely to get the disease. To be vaccinated against mpox, contact your health care provider or local health department.

Mpox resources


Mpox: The State of the Science

APHA and the National Academy of Medicine hosted this free webinar on Aug. 18, 2022. A panel of experts discussed the current state of the science of mpox, the disease epidemiology as we understand it today, available and emergent prevention options, critical research questions we need to answer, and what we should consider and plan for as we respond to this outbreak.

Presenter slides (PDF)

Webinar transcript (PDF)



Read about our speakers.